Ascending Dose Study of HU6 in Healthy Volunteers

Summary

This is a single ascending dose trial in healthy volunteers. The study will be conducted in up to 7 cohorts. Upon review of the safety and PK data, it may be decided to expand the current cohort versus dose escalate to the next cohort. In addition, the sponsor may elect not to enroll all 7 cohorts based on safety and/or PK and/or PD data.

Timeline

Start

2020-08-12

Primary completion

2021-03-30

Completion

2021-04-01

Drugs

Indications